By IQT News posted 15 Oct 2019

(TechCrunch)
Rahko is a new U.K. startup that says it is building “quantum discovery” capabilities for chemical simulation, which could enable groundbreaking advances in batteries, chemicals, advanced materials and drugs.
It’s now raised £1.3 million ($1.6 million) in a seed round led by Balderton Capital, a rare move for a VC that normally only comes in at a Series A level. Joining the round is AI Seed and angel investors Charles Songhurst (former Microsoft head of Corporate Strategy), Tom McInerney (founder, TGM Ventures), John Spindler (CEO, Capital Enterprise) and James Field (CEO, LabGenius).
Chemical simulation is a vital capability for research that has not advanced significantly in recent years due to the limited computational power of classical computers. Rahko claims it has an arsenal of tools that may make quantum computers accessible and commercially usable at an accelerated pace, often through the use of hybrid approaches with classical computers.

Subscribe to Our Email Newsletter

Stay up-to-date on all the latest news from the Quantum Technology industry and receive information and offers from third party vendors.

  • Forthcoming Events

    • IQT Fall | November 1-5, 2021
      Online & In-Person New York City
    • IQT Spring | Dates Forthcoming 2022
      Online & In-Person San Diego
    • For additional information: info@3drholdings.com
0